Amgen Inc. (NASDAQ:AMGN) is considered one of the best cheap stocks for beginners, with a Hold rating and $288.00 price target set by Guggenheim analyst Vamil Divan. The company reported a 9% increase in total revenues to $9.2 billion in fiscal Q2 2025, with GAAP EPS rising 92% to $2.65. Amgen is a biotechnology company focused on developing therapies for complex cancers. While AMGN is seen as a solid investment, other AI stocks may offer greater upside potential. For more investment insights, check out the free report on the best short-term AI stock.

Read more at Yahoo Finance: Guggenheim Maintains a Hold on Amgen Inc. (AMGN)